Pharmaceutical composition for treating gallstones and preparation method of pharmaceutical composition

Abstract

The invention discloses a pharmaceutical composition for treating gallstones. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 10-30 parts of lysimachia christinae hance, 5-20 parts of radix curcumae, 5-15 parts of eucommia ulmoides, 10-30 parts of oriental wormwood, 10-20 parts of scutellaria baicalensis, 5-15 parts of fructus aurantii, 1-5 parts of liquorice, 10-30 parts of radix paeoniae alba, 5-20 parts of albizia flowers, 1-10 parts of polygonum cuspidatum, 1-10 parts of elecampane, 5-15 parts of gentian root and 5-10 parts of radix bupleuri. The pharmaceutical composition for treating gallstones is reasonable in formula, has the functions of soothing the liver, benefiting the gallbladder and promoting qi circulation to relieve pain, and is good in gallstone elimination effect, fast in acting, short in treatment course, free of toxic or side effect, simple in preparation method and convenient to operate on treatment of hepatic calculus and gallstones.

Description

technical field

[0001] The invention relates to the field of gallstone treatment, in particular to a gallstone pharmaceutical composition and a preparation method thereof. Background technique

[0002] Cholelithiasis, also known as cholelithiasis, refers to a disease in which stones occur in the biliary system, including the gallbladder or bile duct; biliary tract infection is a common disease. Divided into cholecystitis and cholangitis according to the site of onset. After the stones form in the gallbladder, they can stimulate the gallbladder mucosa, which can not only cause chronic inflammation of the gallbladder, but also cause secondary infection when the stones are incarcerated in the neck of the gallbladder or the cystic duct, leading to acute inflammation of the gallbladder. Chronic stimulation of the gallbladder mucosa by stones may also lead to the occurrence of gallbladder cancer. It has been reported that the incidence of gallbladder cancer can reach 1% to 2%. ...